跳至主要内容
临床试验/CTRI/2024/01/061201
CTRI/2024/01/061201尚未招募Unknown

A cross sectional study to determine the incidence of hyperchloremia in sepsis and its associated complication among critical patients admitted to ICUs of selected tertiary care hospital, Udupi district. - Nil

Mr Kallesh R0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • The Patients 18 to 80 years of age.
  • Duration of stay in the ICU 24 hours to 72 hours.
  • Patients with sepsis condition with SOFA =2 or APACHE II.

排除标准

  • Patients with symptoms like upper gastrointestinal bleeding, melaena, hematuria, petechiae, or skin lesions that may have hematomas.
  • Individuals with chronic kidney disease.
  • Patient admitted with acute renal damage according to RIFLE criteria. patients undergoing peritoneal dialysis or hemodialysis.
  • Patients taking acetazolamide, methazolamide, dorzolamide, or ethoxzolamide, or any other carbonic anhydrase inhibitor.
  • Chloride on admission greater than one hundred and six mmol per litter

研究者

发起方
Mr Kallesh R

相似试验